1 Market Overview
1.1 Angiotensin II Receptor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Angiotensin II Receptor Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 C-21
1.2.3 EMA-401
1.2.4 KDT-501
1.2.5 MOR-107
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Angiotensin II Receptor Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Immunology
1.3.3 Respiratory
1.3.4 Women’s Health
1.3.5 Acute Ischemic Stroke
1.3.6 Others
1.4 Global Angiotensin II Receptor Market Size & Forecast
1.4.1 Global Angiotensin II Receptor Sales in Value (2016-2026))
1.4.2 Global Angiotensin II Receptor Sales in Volume (2016-2026)
1.4.3 Global Angiotensin II Receptor Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Angiotensin II Receptor Production Capacity Analysis
1.5.1 Global Angiotensin II Receptor Total Production Capacity (2016-2026)
1.5.2 Global Angiotensin II Receptor Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Angiotensin II Receptor Market Drivers
1.6.2 Angiotensin II Receptor Market Restraints
1.6.3 Angiotensin II Receptor Trends Analysis
2 Manufacturers Profiles
2.1 CJ HealthCare Corp
2.1.1 CJ HealthCare Corp Details
2.1.2 CJ HealthCare Corp Major Business
2.1.3 CJ HealthCare Corp Angiotensin II Receptor Product and Services
2.1.4 CJ HealthCare Corp Angiotensin II Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 MorphoSys AG
2.2.1 MorphoSys AG Details
2.2.2 MorphoSys AG Major Business
2.2.3 MorphoSys AG Angiotensin II Receptor Product and Services
2.2.4 MorphoSys AG Angiotensin II Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Angiotensin II Receptor Product and Services
2.3.4 Novartis AG Angiotensin II Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Vicore Pharma AB
2.4.1 Vicore Pharma AB Details
2.4.2 Vicore Pharma AB Major Business
2.4.3 Vicore Pharma AB Angiotensin II Receptor Product and Services
2.4.4 Vicore Pharma AB Angiotensin II Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Angiotensin II Receptor Sales by Manufacturer
3.1 Global Angiotensin II Receptor Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Angiotensin II Receptor Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Angiotensin II Receptor
3.4 Market Concentration Rate
3.4.1 Top 3 Angiotensin II Receptor Manufacturer Market Share
3.4.2 Top 6 Angiotensin II Receptor Manufacturer Market Share
3.5 Global Angiotensin II Receptor Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Angiotensin II Receptor Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Angiotensin II Receptor Market Size by Region
4.1.1 Global Angiotensin II Receptor Sales in Volume by Region (2016-2026)
4.1.2 Global Angiotensin II Receptor Revenue by Region (2016-2026)
4.2 North America Angiotensin II Receptor Revenue (2016-2026)
4.3 Europe Angiotensin II Receptor Revenue (2016-2026)
4.4 Asia-Pacific Angiotensin II Receptor Revenue (2016-2026)
4.5 South America Angiotensin II Receptor Revenue (2016-2026)
4.6 Middle East and Africa Angiotensin II Receptor Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Angiotensin II Receptor Sales in Volume by Type (2016-2026)
5.2 Global Angiotensin II Receptor Revenue by Type (2016-2026)
5.3 Global Angiotensin II Receptor Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Angiotensin II Receptor Sales in Volume by Application (2016-2026)
6.2 Global Angiotensin II Receptor Revenue by Application (2016-2026)
6.3 Global Angiotensin II Receptor Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Angiotensin II Receptor Sales by Type (2016-2026)
7.2 North America Angiotensin II Receptor Sales by Application (2016-2026)
7.3 North America Angiotensin II Receptor Market Size by Country
7.3.1 North America Angiotensin II Receptor Sales in Volume by Country (2016-2026)
7.3.2 North America Angiotensin II Receptor Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Angiotensin II Receptor Sales by Type (2016-2026)
8.2 Europe Angiotensin II Receptor Sales by Application (2016-2026)
8.3 Europe Angiotensin II Receptor Market Size by Country
8.3.1 Europe Angiotensin II Receptor Sales in Volume by Country (2016-2026)
8.3.2 Europe Angiotensin II Receptor Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Angiotensin II Receptor Sales by Type (2016-2026)
9.2 Asia-Pacific Angiotensin II Receptor Sales by Application (2016-2026)
9.3 Asia-Pacific Angiotensin II Receptor Market Size by Region
9.3.1 Asia-Pacific Angiotensin II Receptor Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Angiotensin II Receptor Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Angiotensin II Receptor Sales by Type (2016-2026)
10.2 South America Angiotensin II Receptor Sales by Application (2016-2026)
10.3 South America Angiotensin II Receptor Market Size by Country
10.3.1 South America Angiotensin II Receptor Sales in Volume by Country (2016-2026)
10.3.2 South America Angiotensin II Receptor Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Angiotensin II Receptor Sales by Type (2016-2026)
11.2 Middle East & Africa Angiotensin II Receptor Sales by Application (2016-2026)
11.3 Middle East & Africa Angiotensin II Receptor Market Size by Country
11.3.1 Middle East & Africa Angiotensin II Receptor Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Angiotensin II Receptor Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Angiotensin II Receptor Typical Distributors
12.3 Angiotensin II Receptor Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
【掲載企業】
CJ HealthCare Corp、MorphoSys AG、Novartis AG、Vicore Pharma AB
【免責事項】
https://www.globalresearch.jp/disclaimer